Order Article Reprints
Journal: J. Mark. Access Health Policy, 2021
Volume: 9
Number: 1861804
Article:
Economic Evaluation of Adverse Events of Dabrafenib plus Trametinib versus Nivolumab in Patients with Advanced BRAF-Mutant Cutaneous Melanoma for Adjuvant Therapy in Germany
Authors:
by
S Wahler, A Müller, C Koll, P Seyed-Abbaszadeh and JM Von Der Schulenburg
Link:
https://www.mdpi.com/2001-6689/9/1/1861804
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.